Muhammad Kashif Amin

Clinical Assistant Professor

University of Kansas Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Muhammad Kashif Amin is a Clinical Assistant Professor at The University of Kansas Medical Center in the United States. His research focuses on hematopoietic stem cell transplantation, particularly in the context of acute myeloid leukemia, alloimmune thrombocytopenia, and immunotherapy approaches in hematological malignancies. Recent publications by Dr. Amin explore the impact of treatment strategies and patient characteristics on transplantation outcomes, as well as addressing disparities in end-of-life care.

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (2)

Daniel Arber

Professor and Chair

University of Chicago

UNITED STATES

View details

Muhammad Umair Mushtaq

Assistant Professor of Medicine

University of Kansas Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Muhammad Kashif Amin

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Concurrent intravenous immunoglobulin and platelet transfusion for refractory alloimmune thrombocytopenia in patients undergoing allogeneic hematopoietic stem cell transplantation

Upfront Immunotherapy Approaches in the Management of Adults with Acute Lymphoblastic Leukemia

Impact of FLT3 inhibitors on the outcomes of FLT3-ITD mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplant: A systematic review and meta-analysis

Impact of Measurable Residual Disease Status on Outcomes After HLA-Matched Donor Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia

Impact of body mass index on outcomes following allogeneic hematopoietic stem cell transplantation

Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Myeloid Neoplasms: A Systematic Review and Meta-Analysis

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged 70 Years and Older: A Systematic Review and Meta-Analysis

Favorable outcomes following CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation

Outcomes with HLA-matched unrelated donor versus haploidentical hematopoietic cell transplantation

Bridge the Gap: Addressing Rural End-of-Life Care Disparities and Access to Hospice Services

Comparison of biosimilar filgrastim and originator filgrastim for peripheral blood stem cell mobilization for allogeneic hematopoietic stem cell transplantation

Geographic and Racial Disparities in Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials Access for Diffuse Large B-Cell Lymphoma

What have we learned about TP53-mutated acute myeloid leukemia?

Acute Ischemic Colitis Associated With Oral Phenylephrine Use: A Rare Adverse Effect of a Common Over-the-Counter Drug.

Acute pancreatitis secondary to tamoxifen-associated hypertriglyceridemia: A clinical update.

How does cirrhosis impact mortality, morbidity, and resource utilization in non-variceal upper gastrointestinal bleeding? A nationwide analysis.

Simultaneous Left Ventricular Aneurysm and Ventricular Septal Rupture Complicating Delayed STEMI Presentation: A Case-Based Review of Post-MI Mechanical Complications Amid the COVID-19 Pandemic.

Collaborators (2)

Daniel Arber

Muhammad Umair Mushtaq

Make your next move.